The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

aduro.com

Aduro BioTech has not claimed their Profile.

Want to better differentiate Aduro BioTech between your competitors? Show buyers how.

Hawaii Biotech company logo

Why does Aduro BioTech win vs. Hawaii Biotech?

Show Aduro BioTech's primary competitive advantage

Show Aduro BioTech's competitive differentiation

Aduro BioTech's alternatives and competitors

See how Aduro BioTech compares to similar products. Aduro BioTech's top competitors include Hawaii Biotech, Aerie Pharmaceuticals, and Ocera Therapeutics.

Hawaii Biotech (HBI) is a privately held biotechnology company focused on the research and development of vaccines for established and emerging infectious diseases. The…

Aduro BioTech vs. Hawaii Biotech

View more in-depth data on:

  • Competitors
  • Products
  • Customer References and more
  • Aerie Pharmaceuticals is a privately held, clinical-stage biotechnology company dedicated to the discovery and development of treatments for glaucoma. All technology of…

    Aduro BioTech vs. Aerie Pharmaceuticals

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Ocera Therapeutics is focused on the development and commercialization of therapeutics for gastrointestinal and liver diseases. The company's portfolio consists of OCR-…

    Aduro BioTech vs. Ocera Therapeutics

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Ascendis Pharma is applying its innovative TransCon technology, which combines the benefits of prodrug and sustained release technologies, to develop a pipeline of best…

    Aduro BioTech vs. Ascendis Pharma

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • VLST (Viral Logic Systems Technology) has developed a streamlined and efficient platform that rapidly yields biological therapeutic compositions of matter with a far gr…

    Aduro BioTech vs. VLST Corporation

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Neurotech is a spin-off of the UniversitA© catholique de Louvain and has been funded by SOPARTEC, the technology transfer company of UniversitA© catholique de Louvain, …

    Aduro BioTech vs. Neurotech

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Merrimack Pharmaceuticals (NASDAQ: MACK) is a biopharmaceutical company discovering, developing, and commercializing medicines paired with companion diagnostics for the…

    Aduro BioTech vs. Merrimack Pharmaceuticals

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • TechnoVax is a privately held biotechnology company and specializes in vaccine development. The company aims to begin clinical trials within the next 18 months.

    Aduro BioTech vs. TechnoVax

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • ERA Biotech develops and implements cell-based biomanufacturing technologies.

    Aduro BioTech vs. ERA Biotech

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • ASC is a privately held biotechnology company dedicated to the development and commercialization of enabling technologies to enhance and expand the therapeutic potentia…

    Aduro BioTech vs. American Stem Cell

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • BioVascular Inc. is a privately held biotechnology company that develops drugs and devices for the control of intimal hyperplasia associated with vascular procedures an…

    Aduro BioTech vs. Biovascular

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • BioRegenix is a biotechnology company committed to the development of tissue regeneration technology.

    Aduro BioTech vs. BioRegenix

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Anaborex Anaborex is an early stage biotechnology company developing drugs for the treatment of the wasting syndrome many cancer patients experience towards the late st…

    Aduro BioTech vs. Anaborex

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • ARC Pharmaceuticals Inc. is a privately owned biotechnology company developing medical products for the treatment of proliferative diseases. The Company holds exclusi…

    Aduro BioTech vs. ARC Pharmaceuticals

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • 7TM Pharma is a discovery and development biotech company with focus on new pharmaceutical drugs targeting 7TM receptors.

    Aduro BioTech vs. 7TM Pharma

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more

You May Also Like

T
TechnoVax

TechnoVax is a privately held biotechnology company and specializes in vaccine development. The company aims to begin clinical trials within the next 18 months.

O
Osprey Pharmaceuticals

Osprey Pharmaceuticals is a privately held biotechnology company focused on developing and commercializing a first-in-class family of therapeutic proteins (Leukocyte Population Modulators) capable of treating chronic diseases. Osprey's broad technology platform is based on the critical insight that many common diseases are propagated by overabundant and overactive leukocytes. The company's proprietary LPMs selectively and systematically destroy disease-related leukocytes by infiltrating the chemokine system that regulates the movement and activity of leukocytes.

N
Nuvelo

Nuvelo, Inc. is dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular and cancer therapy. Nuvelo's development pipeline includes alfimeprase, a direct-acting fibrinolytic for the treatment of thrombotic- related disorders including acute ischemic stroke and catheter occlusion and preclinical candidates NU206 for the potential treatment of chemotherapy/radiation therapy-induced mucositis and inflammatory bowel disease and NU172, a direct thrombin inhibitor for use as a short-acting anticoagulant during medical or surgical procedures. In addition, Nuvelo expects to leverage its expertise in cancer antibody discovery to further expand its pipeline and create additional partnering and licensing opportunities.

F
FIBREX Medical

FIBREX Medical Inc. is a development stage bio-pharmaceutical company. Its operational affiliate FIBREX Medical Research & Development GmbH was established in Vienna in February 2001. The company is focused on pharmaceuticals targeting fundamental mechanisms of inflammation and tissue injury. Per FIBREX, while inflammation is highly desirable to defend the organism against foreign particles and infections, it can become harmful and destructive if it runs unchecked. Inflammation-based tissue injury is well known as a major component in the pathogenesis and progression of important diseases such as myocardial infarction, septic and hemorrhagic shock, graft rejection, or rheumatoid arthritis. In addition, endothelial dysfunction in inflamed tissues leads to capillary leak and deleterious edema formation, aggravating organ dysfunction.

A
AgaPharm

AgaPharm is developing a prescription eye drop for Diabetics. The drug aims to offer a simple, low-cost treatment that can deliver a safe and effective dose to the eye, preventing or slowing down the onset of diabetic blindness and cataract. The company's Research Partner is the Biotechnology Research Institute at the National Research Council of the Government of Canada.

Noveome Biotherapeutics Logo
Noveome Biotherapeutics

Noveome Biotherapeutics is regenerative medicine company focused on the research, development and clinical use of its technology platform, derived from human placental cells. This platform provides a new approach to tissue regeneration and repair in a wide range of medical conditions. Noveome's technology platform is derived from a population of cells isolated from full-term placental tissue that is normally discarded following delivery of a baby. There is no interruption in the development of the baby to procure this tissue.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.